GLP-1 Research
A research-backed comparison of GLP-1 medications and traditional diet plans — what the clinical data reveals about weight…
GLP-1 supplements claim to mimic prescription weight-loss drugs naturally, but the science reveals a significant gap between stimulating…
New clinical trial data — including the landmark FLOW trial — suggests semaglutide may actually protect kidney function…
New research shows GLP-1 receptor agonists deliver significant cardiovascular benefits — including a 42% reduction in atrial fibrillation…
GLP-1 medications can drive significant weight loss, but research shows over 10% of muscle mass can be lost…
GLP-1 medications like semaglutide work by mimicking a natural gut hormone to suppress appetite, slow digestion, improve insulin…
New research confirms that no single baseline characteristic reliably predicts who will respond to GLP-1 therapy — but…
Ozempic follows a graduated dosing protocol starting at 0.25 mg weekly and escalating up to 2 mg —…
Up to 45% of weight lost on semaglutide can come from muscle — here's what the science says…
New research reveals that GLP-1 receptor agonists may actually support bone formation at the cellular level — but…